HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Shaolin Temple abbot's case sparks alarm in Buddhist community
- Rare glossy ibis returns to North China wetland after 15-year absence
- Immersive program turns history into experience at Yangguan Pass
- Zhengzhou metro suspends stations amid heavy rain
- Final missing mountain collapse victim found in Guangzhou
- Huzhou prospers through coordinated sustainable development